Tanmoy Ganguly

Tanmoy Ganguly has 26 years of work experience in the field of biotechnology and pharmaceuticals. Tanmoy is currently the Chief Scientific Officer at GlycoEra AG since May 2022. Previously, they worked at Evelo Biosciences as the Vice President in-vitro Pharmacology from October 2018 to April 2022. Prior to that, they held various roles at Momenta Pharmaceuticals from January 2007 to October 2018, including Sr. Director, Director, Associate Director, and Principal Scientist. Tanmoy also worked at BD Biosciences as a Research Scientist from 2005 to 2006. Tanmoy Ganguly served as an Associate Director, Molecular and Cell Biology, and a Principal Scientist at UCB Pharma from January 2001 to January 2004. Tanmoy was a Scientist II at Millennium Pharmaceuticals from April 1999 to November 2001. Tanmoy Ganguly started their career at Helios Pharmaceuticals as a Staff Researcher II, Molecular Pharmacology from September 1997 to January 1999, where they were responsible for the development of high-throughput screening assays. Tanmoy also has experience as a Postdoctoral Researcher at the University of Kentucky from 1995 to 1997, working on the molecular mechanisms of hormonal regulation, and as a Postdoctoral Fellow at the University of Alabama at Birmingham from 1994 to 1995, focusing on the characterization of human cytosolic sulfotransferases.

Tanmoy Ganguly pursued their education in pharmacology and pharmacy. Tanmoy earned their Bachelor of Pharmacy degree from Bombay College of Pharmacy Kalina, Mumbai, during the years 1984 to 1988. Following this, they went on to pursue a Ph.D. in Pharmacology from the University of Kentucky, completing it between 1989 and 1994.

In addition to their formal education, Tanmoy Ganguly also obtained a certification called the "Certificate Program for Institute for BioMedical Entrepreneurship" from the Institute for Biomedical Entrepreneurship, Inc. (IBE, Inc.) in the year 2016. However, no specific month of when they obtained this certification is mentioned.